Welcome : Guest

Theravance Biopharma, Inc. (Cayman Islands) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Theravance Biopharma, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 55 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-65557
Price: $2750
Company Type: Public
Pages: 58
Date: November 2016
Market Data Tables: 55

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Theravance Biopharma, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for U.S., Europe, Asia, and Others......3
Infectious Disease Drugs......5
Table 2: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......5
Table 3: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......6
Pain Drugs......7
Table 4: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......7
Central Nervous System (CNS) Drugs......8
Table 5: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......8
Table 6: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......9
Respiratory Drugs......10
Table 7: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......10
Table 8: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......11
Gastrointestinal Drugs......12
Table 9: Gastrointestinal Market Worldwide (2015) in US$ Million......12
Table 10: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......13
Chronic Obstructive Pulmonary Disease (COPD) Drugs......14
Table 11: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......14
Table 12: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......15
Table 13: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......16
Table 14: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......17
Asthma Drugs......18
Table 15: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......18
Table 16: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......19
Table 17: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......20
Hepatitis C......21
Table 18: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others......21
Table 19: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......22
Table 20: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......23
Table 21: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......24
Table 22: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......25
Table 23: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......26
Table 24: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......27
Table 25: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......28
Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics......29
Table 26: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......29
Table 27: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......30
Cardiology Therapeutics......31
Table 28: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......31
Table 29: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......32
Table 30: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......33
Kidney Disease Drugs......34
Table 31: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......34
Table 32: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......35
Table 33: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......36
Table 34: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......37
Table 35: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......38
Table 36: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......39
Table 37: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......40
Infectious Disease Drugs......41
Table 38: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......41
Central Nervous System (CNS) Medicines......42
Table 39: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......42
Table 40: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......43
Pain Management Drugs......44
Table 41: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......44
Table 42: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......45
Table 43: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......46
Table 44: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......47
Table 45: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Other......48
Table 46: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......49
Respiratory Therapeutics......50
Table 47: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......50
Gastrointestinal Drugs......51
Table 48: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......51
Table 49: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......52
Table 50: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......53
Table 51: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......54
Table 52: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......55
HBV/HCV Therapeutics......56
Table 53: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......56
Table 54: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......57
Cardiology Therapeutics......58
Table 55: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......58